Skip to content

Effects of enteral nutrition enriched with omega-3 fatty acids on outcome in non-small cell lung cancer patients.

Effects of enteral nutrition enriched with omega-3 fatty acids on outcome in non-small cell lung cancer patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25348
Enrollment
40
Registered
2005-09-08
Start date
2005-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

Group A (n=20) will receive 2 packages per day of a nutritional supplement with 2 g EPA. Group B(n=20) will receive 2 packages per day of a control nutritional supplement.

Sponsors

VUmc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 to 75 years; 2. Diagnosis NSCLC stage III; 3. Resolved treatment plan: neo-adjuvant chemo(radiation)therapy during 6 weeks and, dependent on disease regression, tumour resection; 4. Life expectancy greater than 3 months; 5. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Surgery, chemo- or radiation therapy during the previous month; 2. Oedema or ascites; 3. Use of fish oil supplements during the last month; 4. Use of high dose corticosteroids (low dose, inhalation steroids and/or local use is permitted); 5. Other active medical conditions (major gastrointestinal disease, chronic renal failure, uncontrolled diabetes mellitus, HIV).

Design outcomes

Primary

MeasureTime frame
1. Muscle strength; 2. Immune status; 3. Nutritional status; 4. Cancer cachexia.

Secondary

MeasureTime frame
1. Quality of life (QOL); 2. Physical activity level (PAL); 3. Post-operative complications and survival.

Contacts

Public ContactB. Meij, van der

VU Medical Center, P.O. Box 7057

b.vandermeij@vumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)